These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7537751)

  • 1. Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots.
    Gürtler LG; Zekeng L; Simon F; Eberle J; Tsague JM; Kaptue L; Brust S; Knapp S
    J Virol Methods; 1995 Feb; 51(2-3):177-83. PubMed ID: 7537751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples.
    van Binsbergen J; Keur W; vd Graaf M; Siebelink A; Jacobs A; de Rijk D; Toonen J; Zekeng L; Afane Ze E; Gürtler LG
    J Virol Methods; 1997 Dec; 69(1-2):29-37. PubMed ID: 9504748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type.
    Josephson SL; Swack NS; Ramirez MT; Hausler WJ
    J Clin Microbiol; 1989 May; 27(5):932-7. PubMed ID: 2501354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new third generation anti-HIV-1/anti-HIV-2 assay with increased sensitivity for HIV-1 group O.
    van Binsbergen J; de Rijk D; Peels H; Dries C; Scherders J; Koolen M; Zekeng L; Gürtler LG
    J Virol Methods; 1996 Jul; 60(2):131-7. PubMed ID: 8844618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of viral-lysate enzyme-linked immunosorbent assay kits for detecting human immunodeficiency virus (type 1) infections using human sera standardized by quantitative western blotting.
    Hardy CT; Damrow TA; Villareal DB; Kenny GE
    J Virol Methods; 1992 Jun; 37(3):259-73. PubMed ID: 1378850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area.
    Andersson S; da Silva Z; Norrgren H; Dias F; Biberfeld G
    AIDS; 1997 Dec; 11(15):1815-22. PubMed ID: 9412699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus (HIV) antibodies detected by new assays that are enhanced for HIV-1 subtype O.
    Jongerius JM; van der Poel CL; van Loon AM; van den Akker R; Schaasberg W; van Leeuwen EF
    Transfusion; 1997 Aug; 37(8):841-4. PubMed ID: 9280330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV-1 antibodies based confirmatory results in Wuhan, China, 2012-2018.
    Liu P; Tang L; Kong WH; Zhu ZR; Xiao P; Wang X; Zhou W; Liu MQ
    PLoS One; 2020; 15(9):e0238282. PubMed ID: 32915788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a quantitative double ELISA strategy for confirmation and differentiation of HIV infection.
    Rehle TM; Mattke P; Liomba GN; Krämer S; Gershy-Damet GM; Konan K; Sangare A; Zekeng L; Tsague JM; Kaptue L; Eberle J; Gürtler L
    J Virol Methods; 1997 Jul; 66(2):203-9. PubMed ID: 9255731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographical distribution of HIV-1 group O viruses in Africa.
    Peeters M; Gueye A; Mboup S; Bibollet-Ruche F; Ekaza E; Mulanga C; Ouedrago R; Gandji R; Mpele P; Dibanga G; Koumare B; Saidou M; Esu-Williams E; Lombart JP; Badombena W; Luo N; Vanden Haesevelde M; Delaporte E
    AIDS; 1997 Mar; 11(4):493-8. PubMed ID: 9084797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 antibody testing strategy: evaluation of ELISA screening and western blot profiles in a mixed low risk/high risk patient population.
    Downie JC; Howard R; Bowcock B; Cunningham AL
    J Virol Methods; 1989 Dec; 26(3):291-303. PubMed ID: 2695539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HIV antibody and antigen/antibody combination ELISAs for use in an alternative confirmatory HIV testing strategy in Dar es Salaam, Tanzania.
    Aboud S; Urassa W; Lyamuya E; Mhalu F; Biberfeld G
    J Virol Methods; 2006 Aug; 135(2):192-6. PubMed ID: 16647764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains.
    Corrigan GE; Al-Khalili L; Malmsten A; Thorstensson R; Fenyö EM; Källander CF; Gronowitz JS
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):347-52. PubMed ID: 9519896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network.
    Gorse GJ; Frey SE; Patel G; Newman FK; Belshe RB
    Vaccine; 1994 Aug; 12(10):912-8. PubMed ID: 7975833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False negative anti-HIV-1/HIV-2 ELISAs in acute HIV-2 infection.
    Christiansen CB; Jessen TE; Nielsen C; Staun-Olsen P
    Vox Sang; 1996; 70(3):144-7. PubMed ID: 8740005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1.
    Keay S; Tacket CO; Murphy JR; Handwerger BS
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1091-8. PubMed ID: 1503823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in serologic screening of corneal donors for HIV-1 and hepatitis B virus infections.
    Pepose JS; Buerger DG; Paul DA; Quinn TC; Darragh TM; Donegan E
    Ophthalmology; 1992 Jun; 99(6):879-88. PubMed ID: 1630777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.